Sign in Subscribe

Nox Health

U.S. private equity firm invests heavily in Nox Health

U.S. private equity firm invests heavily in Nox Health

Nox Health, the Icelandic sleep health company with global operations, recently announced a strategic growth investment from Vestar Capital Partners, a U.S. middle-market private equity firm. Vestar will acquire shares from existing shareholders, mainly Alfa Framtak, as well as newly issued shares. The investment will help Nox accelerate the

Nox Medical and Fusion Health merge to form Nox Health, with $10m investment from from private equity firm Alfa Framtak

Nox Medical and Fusion Health merge to form Nox Health, with $10m investment from from private equity firm Alfa Framtak

Nox Medical, the Icelandic maker of sleep monitoring and diagnostics devices, and FusionHealth, have merged to become Nox Health. As part of the merger, Icelandic private equity fund Alfa Framtak has invested $10m in the company for a 13% stake in the company. “The merger with FusionHealth, which is now